How early can we predict Alzheimer's disease using computational anatomy?

@article{Adaszewski2013HowEC,
  title={How early can we predict Alzheimer's disease using computational anatomy?},
  author={Stanislaw Adaszewski and Juergen Dukart and Ferath Kherif and Richard S. Frackowiak and Bogdan Draganski},
  journal={Neurobiology of Aging},
  year={2013},
  volume={34},
  pages={2815-2826}
}
Computational anatomy with magnetic resonance imaging (MRI) is well established as a noninvasive biomarker of Alzheimer's disease (AD); however, there is less certainty about its dependency on the staging of AD. We use classical group analyses and automated machine learning classification of standard structural MRI scans to investigate AD diagnostic accuracy from the preclinical phase to clinical dementia. Longitudinal data from the Alzheimer's Disease Neuroimaging Initiative were stratified… Expand
Assessing Mild Cognitive Impairment Progression using a Spherical Brain Mapping of Magnetic Resonance Imaging.
TLDR
The results prove that Spherical Brain Mapping offers good ability to predict conversion patterns and cognitive state, at the same time that provides an additional aid for visualizing a two-dimensional abstraction map of the brain. Expand
Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects
TLDR
The results presented in this study demonstrate the potential of the suggested approach for early AD diagnosis and an important role of MRI in the MCI-to-AD conversion prediction. Expand
Voxel-MARS: a method for early detection of Alzheimer’s disease by classification of structural brain MRI
TLDR
A fully-automated voxel-based procedure, Voxel-MARS, for detection of AD and MCI in early stages of progression is introduced and it was shown that the proposed method is promising in early detection ofAD. Expand
Prediction and classification of Alzheimer disease based on quantification of MRI deformation
TLDR
A machine learning method to discriminate patients with AD or mild cognitive impairment (MCI) from healthy elderly and to predict the AD conversion in MCI patients by computing and analyzing the regional morphological differences of brain between groups is proposed. Expand
Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
TLDR
The results indicate that fully independent classifiers built only on AD and controls data and combining imaging, genetic, and/or neuropsychological biomarkers can more reliably discriminate between stable and converter MCI than single modality classifiers. Expand
Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer’s disease dementia: a systematic review
TLDR
A systematic review of studies where machine learning was applied to neuroimaging data in order to predict whether patients with mild cognitive impairment might develop Alzheimer’s disease dementia or remain stable found this methodology has a great potential as a support tool for clinicians and healthcare professionals. Expand
Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study
TLDR
This first application of a MRI-based pattern recognition method to a routine sample demonstrates feasibility, but also illustrates that automated multi-class differential diagnoses have to be the focus of future methodological developments and application studies. Expand
Early prediction of Alzheimer’s disease using longitudinal volumetric MRI data from ADNI
TLDR
A longitudinal data prediction framework based on functional data analysis to identify when an early prediction of AD can reasonably be made is developed and shows that these ROI volumes have prediction power as early as 3 years in advance. Expand
Comparison of feature representations in MRI-based MCI-to-AD conversion prediction.
Alzheimer's disease (AD) is a progressive neurological disorder in which the death of brain cells causes memory loss and cognitive decline. The identification of at-risk subjects yet showing noExpand
COMPUTERIZED TOOLS: A SUBSTITUTE OR A SUPPLEMENT WHEN DIAGNOSING ALZHEIMER'S DISEASE?
Alzheimer’s disease (AD) is the most common form of dementia in the elderly characterized by difficulties in memory, disturbances in language, changes in behavior, and impairments in daily lifeExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 61 REFERENCES
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease
TLDR
A novel data mining framework is developed in combination with three different classifiers including support vector machine (SVM), Bayes statistics, and voting feature intervals (VFI) to derive a quantitative index of pattern matching for the prediction of the conversion from MCI to AD. Expand
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.
TLDR
Semiautomated, individually specific quantitative MR imaging methods can be used to identify a pattern of regional atrophy in MCI that is predictive of clinical decline and structural loss that may aid in prediction of patient prognosis and increase the efficiency of clinical trials. Expand
Automatic classification of MR scans in Alzheimer's disease.
TLDR
Assessment of support vector machines assigned individual diagnoses and whether data-sets combined from multiple scanners and different centres could be used to obtain effective classification of scans suggests an important role for computer based diagnostic image analysis for clinical practice. Expand
Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
TLDR
It is demonstrated that structural brain changes occur years before clinical cognitive decline in AD and are localized to regions affected by AD neuropathology. Expand
MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults
TLDR
This approach to the detection of individuals at high risk for preclinical AD—identified in single CN individuals using this quantitative ADsig MRI biomarker—may provide investigators with a population enriched for AD pathobiology and with a relatively high likelihood of imminent cognitive decline consistent with prodromal AD. Expand
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
TLDR
Results suggest that imaging-based spatial patterns of brain atrophy of Alzheimer's disease, evaluated with sophisticated pattern analysis and recognition methods, may be useful in discriminating among CN individuals who are likely to be stable versus those who will show cognitive decline. Expand
Neural correlates of Alzheimer's disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients
TLDR
A systematic and quantitative meta-analysis reveals that early Alzheimer's disease affects structurally the (trans-)entorhinal and hippocampal regions, functionally the inferior parietal lobules and precuneus and contributes to standardized imaging inclusion criteria for Alzheimer's Disease as suggested for future diagnostic systems. Expand
Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study
TLDR
This work builds upon previous studies that reported high sensitivity and specificity in classifying individuals with mild cognitive impairment (MCI), and tests the hypothesis that joint evaluation of structure and function can yield higher classification accuracy than either alone. Expand
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance
TLDR
Short-term conversion to AD is predicted by single marker models to a comparable degree as by multimarker models in amnestic MCI subjects. Expand
Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
TLDR
In summary, both SPARE-AD and CSF biomarkers showed high baseline sensitivity, however, many MCI-NC had abnormal baseline Spatial Pattern of Abnormalities for Recognition of Early AD and CSFs, and longer follow-up will elucidate the specificity of baseline measurements. Expand
...
1
2
3
4
5
...